For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…
Cardiopulmonary Autotransfusion System is a sophisticated device with an exceptionally effective design that provides autologous blood during surgical procedures.
Autotransfusion is a process wherein a person receives their own blood for a transfusion, instead of banked allogenic (separate-donor) blood. There are two main kinds of Autotransfusion: Blood can be autologous "pre-donated" (termed so despite "donation" not typically referring to giving to one's self) before a surgery, or alternatively, it can be collected during and after the surgery using an intraoperative blood salvage device. The latter form of Autotransfusion is utilized in surgeries where there is expected a large volume blood loss.
LPI (LP Information)' newest research report, the "Cardiopulmonary Autotransfusion System Industry Forecast" looks at past sales and reviews total world Cardiopulmonary Autotransfusion System sales in 2022, providing a comprehensive analysis by region and market sector of projected Cardiopulmonary Autotransfusion System sales for 2023 through 2029. With Cardiopulmonary Autotransfusion System sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Cardiopulmonary Autotransfusion System industry.
This Insight Report provides a comprehensive analysis of the global Cardiopulmonary Autotransfusion System landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Cardiopulmonary Autotransfusion System portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Cardiopulmonary Autotransfusion System market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Cardiopulmonary Autotransfusion System and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Cardiopulmonary Autotransfusion System.
The global Cardiopulmonary Autotransfusion System market size is projected to grow from US$ 541 million in 2022 to US$ 642.6 million in 2029; it is expected to grow at a CAGR of 642.6 from 2023 to 2029.
The major players in global Cardiopulmonary Autotransfusion System market include Haemonetics, Medtronic, LivaNova, etc. The top 3 players occupy about 70% shares of the global market. North America and Europe are main markets, they occupy about 80% of the global market. Washed ATS is the main type, with a share about 90%. Heart Surgery is the main application, which holds a share about 35%.
This report presents a comprehensive overview, market shares, and growth opportunities of Cardiopulmonary Autotransfusion System market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
- Unwashed ATS
- Washed ATS
Segmentation by application
- Heart Surgery
- Great Organ Transplant Surgery
- Other Surgery
This report also splits the market by region:
- Americas
- - United States
- - Canada
- - Mexico
- - Brazil
- APAC
- - China
- - Japan
- - Korea
- - Southeast Asia
- - India
- - Australia
- Europe
- - Germany
- - France
- - UK
- - Italy
- - Russia
- Middle East & Africa
- - Egypt
- - South Africa
- - Israel
- - Turkey
- - GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
- Haemonetics
- Medtronic
- LivaNova
- Fresenius Kabi
- Terumo
- Wandong Health Sources
Key Questions Addressed in this Report
What is the 10-year outlook for the global Cardiopulmonary Autotransfusion System market?
What factors are driving Cardiopulmonary Autotransfusion System market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Cardiopulmonary Autotransfusion System market opportunities vary by end market size?
How does Cardiopulmonary Autotransfusion System break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?